UBS raised the firm’s price target on Exelon (EXC) to $50 from $48 and keeps a Neutral rating on the shares.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on EXC:
- Exelon: Strong Regulatory Environment and Growth Prospects Justify Buy Rating
- Exelon initiated with an Outperform at Evercore ISI
- Exelon: Strategic Growth and Attractive Risk-Return Profile Amidst Regulatory Clarity
- Exelon price target lowered to $49 from $50 at Morgan Stanley
- Sunrun, BGE activated first residential vehicle-to-grid power plant